Elios

Wishing everyone a very Merry Christmas and a Happy New Year! lnkd.in/emRceZXT ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

I’ve been working very closely with @elios_vision for many years in pre-clinical and clinical studies. Great to see @BauschLomb acquire this technology now to take it to the mass market! Let’s get this excimer laser based #migs to our #glaucoma patients! bausch.com/news/?id=239

.@bauschlomb buys @elios_vision to boost #glaucoma treatment: hubs.li/Q02_gC-q0

Dr. Jose Belda @drbelda joined Professor @gusgazzard and Dr. Nishani Amerasinghe for Episode 11 of the Interventional Glaucoma Podcast. In the episode, they explore Routine Phaco Plus and its impact on glaucoma treatment, discussing how it combines cataract surgery with MIGS to manage glaucoma while improving patient quality of life. Tune in to hear about its growing adoption across Europe and the exciting potential this technique holds. Now streaming on Apple, Spotify, and YouTube! eliosvision.com/ous/podcast/ #theIGpodcast #Glaucoma #Ophthalmology #CataractSurgery #PatientCare #Elios #Visionker eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

We are excited for Dr. Nishani Amerasinghe to join Professor @gusgazzard and Dr. Jose Belda for Episode 11 of the Interventional Glaucoma Podcast! In this episode, they discuss the exciting potential of Routine Phaco Plus, an approach combining cataract surgery with MIGS to enhance glaucoma patient care. They share our thoughts on its safety, adoption, and how it’s helping improve quality of life for patients across Europe. Listen to the episode now on Apple, Spotify, and YouTube! eliosvision.com/ous/podcast/ #theIGpodcast #Glaucoma #Ophthalmology #CataractSurgery #PatientCare #Elios #UKGlaucomaSociety eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Professor Gus Gazzard @gusgazzard hosts Episode 11 of the Interventional Glaucoma Podcast. In this episode, he is joined by Dr. Nishani Amerasinghe and Dr. Jose Belda to discuss Routine Phaco Plus. They explore the benefits of combining cataract surgery with MIGS, the role of Phaco Plus in improving patient outcomes, and how it’s being adopted across Europe. Learn about the current state of this innovative procedure and its long-term benefits for glaucoma patients. Available now on Apple, Spotify, and YouTube. eliosvision.com/ous/podcast/ #theIGpodcast #Glaucoma #Ophthalmology #CataractSurgery #PatientCare #Elios #MoorfieldsEyeHospital eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Join Professor Gus Gazzard as he hosts Dr. Nishani Amerasinghe and Dr. Jose Belda for Episode 11 of the Interventional Glaucoma Podcast. This episode examines the concept of Routine Phaco Plus, discussing its benefits, safety, and how it’s changing the treatment of glaucoma across Europe. Our host and guests explore patient outcomes, the procedure’s adoption in different regions, and how Phaco Plus could delay more invasive surgeries. Don’t miss this insightful conversation. Listen now on Apple, Spotify, and YouTube! eliosvision.com/ous/podcast/ #theIGpodcast #Glaucoma #Ophthalmology #CataractSurgery #PatientCare #Elios eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Elios Vision are proud to support the innovative new podcast series – ‘Outlier’s Insights’ by sponsoring the first episode Listen in as hosts Gok Ratnarajan, Paul Singh and Ben LaHood discuss key insights with top Ophthalmology experts – Episode 1 featuring none other than Ike Ahmed. Subscribe to The Outlier’s Insights podcast here: outliersinsights.podbean.com #Outliersinsights #theIGpodcast #EliosVision #Glaucoma #Ophthalmology

Mr. Gok Ratnarajan joins Dr. Karl Mercieca and Dr. Ana Miguel in Episode 10 of the Interventional Glaucoma Podcast, recorded live at the EGS Congress in Dublin. This episode focuses on the future of glaucoma management and treatment, discussing where the field will be in the next five years. Mr. Ratnarajan provides his perspective shares on the current challenges regarding glaucoma care in the UK, notably diving into how patients are becoming more educated, and as a result, more ‘demanding’. Catch the episode now on Apple, Spotify, and YouTube. eliosvision.com/ous/podcast/ #theIGpodcast #EliosVision #Glaucoma #FutureOfGlaucoma #Ophthalmology #PatientCare #EGS2024 eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Dr. Ana Miguel joins Dr. Karl Mercieca and Mr. Gok Ratnarajan in Episode 10 of the Interventional Glaucoma Podcast. This episode explores the future landscape of glaucoma management and treatment, projecting where we will be in five years. Dr. Miguel shares her insights about the current challenges regarding glaucoma care in France and her opinions about emerging technologies and methodologies poised to transform patient care and treatment outcomes. Tune in to the episode now on Apple, Spotify, and YouTube. eliosvision.com/ous/podcast/ #theIGpodcast #EliosVision #Glaucoma #FutureOfGlaucoma #Ophthalmology #PatientCare #EGS2024 #disclaimer" target="_blank" rel="nofollow noopener">eliosvision.com/#disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Join Dr Karl Mercieca as he hosts Dr. Ana Miguel and Mr. Gok Ratnarajan in the tenth episode of the IG Podcast. This episode explores the future of glaucoma management and treatment, considering where we might be in five years’ time. Our guests share their country-specific insights and discuss the advancements in technology and methodologies that will shape the landscape of glaucoma care, offering a glimpse into the future of patient treatment and well-being. Curious to know what the future of glaucoma care might be? Listen to the episode now on Apple, Spotify, and YouTube. eliosvision.com/ous/podcast/ #theIGpodcast #EliosVision #Glaucoma #FutureOfGlaucoma #Ophthalmology #EliosPodcast #PatientCare #EGS2024 eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Elios Vision are proud to be supporting UKEGS 2024 & Dr Nishani Amerasinghe in Southampton on 9th– 10th October. Come and say hello at our exhibition booth and hear about ELIOS, the first clinically validated Excimer Laser MIGS. For more insight into the Interventional Glaucoma mindset, subscribe to The IG Podcast series at eliosvision.com/ous/podcast/ #UKEGS2024 #Glaucoma #Elios #EliosVision #Ophthalmology eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

‘Aim high to get low (pressures)’ Dan Lindfield @EyeSurgeonDan shares his insight into correct technique for trabecular meshwork #MIGS allowing for the Parallax Effect theophthalmologist.com/business-profe… For more insight into the Interventional Glaucoma mindset, subscribe to The IG Podcast series at eliosvision.com/ous/podcast/ #UKEGS2024 #theIGpodcast #EliosVision #Glaucoma #Ophthalmology eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Join world-renowned glaucoma leaders as they engage in unscripted discussions about the latest innovations in Interventional Glaucoma and how applying new technologies in routine practice could improve patient-centred care. Subscribe to The Interventional Glaucoma Podcast series and further explore the Interventional Glaucoma mindset. Visit eliosvision.com/ous/podcast/ (available on Apple / Spotify / YouTube) #theIGpodcast #EliosVision #Glaucoma #Ophthalmology #EliosPodcast eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Elios Vision is proud to be supporting the DOG in Berlin on 10-12 October. Visit our exhibition booth where our team will be pleased to inform you about ELIOS, the first clinically validated Excimer Laser MIGS. Don't miss the opportunity to take part in our Meet the Experts with Prof. Dr. Swaantje Grisanti on October 11, 16:15 – 16:45 pm. #DOG #Glaucoma #Elios #EliosVision #Ophthalmology eliosvision.com/disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Elios Vision are excited to be attending the 100th Congress of the Sociedad Espanola de Oftalmologia (SEO) in Madrid on the 25th-27th September. Come by our booth, where our team are excited to create successful and exciting conversations about ELIOS - the first clinically validated excimer laser MIGS procedure! #seo2024 #Glaucoma #Elios #EliosVision #Excimerlaser #Ophthalmology #disclaimer" target="_blank" rel="nofollow noopener">eliosvision.com/#disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

Join Dr. Jose Belda as he hosts Dr. María Isabel Canut and Dr. Marta Ibarz in Episode 9 of the IG Podcast! Recorded live at EGS in Dublin, this episode brings together leading Spanish ophthalmologists to delve into the benefits of combining MIGS with cataract surgery and its transformative impact on patient postoperative care. Our expert guests share their experiences with ELIOS, exploring data on its safety and efficacy. Discover how this innovative treatment improves patient quality of life by listening to the episode now on Apple, Spotify, and YouTube. eliosvision.com/ous/podcast/ep… #disclaimer" target="_blank" rel="nofollow noopener">eliosvision.com/#disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.

That's a wrap for #eliosvision in Barcelona at the #escrs2024 Thank you to everyone for making this year's ESCRS such a great meeting #Glaucoma #Elios #Excimerlaser #disclaimer" target="_blank" rel="nofollow noopener">eliosvision.com/#disclaimer ELIOS is not approved for sale in the United States, where it is limited by Federal law to investigational use.